Navigation Links
Study Finds Many Flu Patients Not Treated Appropriately
Date:7/17/2014

THURSDAY, July 17, 2014 (HealthDay News) -- Antiviral drugs aren't prescribed often enough for patients at high risk for flu complications, while too many of them receive unneeded antibiotics, a new study says.

The findings show that doctors require more training about the proper use of antiviral and antibiotic drugs in treating flu patients, the researchers said. Unnecessary use of antibiotics contributes to the development of antibiotic resistance.

"Our results suggest that during 2012-13, antiviral medications were underprescribed and antibiotics may have been inappropriately prescribed to a large proportion of outpatients with influenza," wrote Dr. Fiona Havers and colleagues from the U.S. Centers for Disease Control Prevention and several other institutions.

The researchers analyzed data from about 6,800 patients with flu symptoms seen at five outpatient care centers in Michigan, Pennsylvania, Texas, Wisconsin and Washington state during the 2012-13 flu season. The team focused on prescription records for two antiviral drugs for flu -- oseltamivir (Tamiflu) and zanamivir (Relenza) -- and three widely used antibiotics (amoxicillin-clavulanate, amoxicillin, and azithromycin).

Antiviral drugs were prescribed to only 19 percent of patients who were at high risk for flu complications and saw a primary care provider within two days of their flu symptoms emerging. And only 16 percent of patients with laboratory-confirmed flu got oseltamivir or zanamivir.

However, 30 percent of these patients were prescribed antibiotics, which are typically ineffective against flu unless it has progressed to a bacterial infection, according to the study. The study was published July 17 in the journal Clinical Infectious Diseases.

"Continuing education on appropriate antibiotic and antiviral use is essential to improve health care quality," the researchers said.

The author of an accompanying editorial, Dr. Michael Ison, said benefits associated with antiviral therapy for influenza include fewer lower respiratory infections and hospitalizations and reduced antibiotic use and stroke risk.

The study "demonstrates that we are clearly failing our patients by not providing antiviral therapy to patients with influenza consistent with current guidelines while exposing many of the patients to antibiotics from which they likely derive little benefit," wrote Ison, associate professor of infectious diseases and organ transplantation at the Northwestern University Feinberg School of Medicine in Chicago.

The elderly, very young children and people with certain chronic diseases are considered at high risk of flu complications, including pneumonia and bronchitis. Pregnant women also fall into the high-risk category, according to the CDC.

More information

The U.S. Centers for Disease Control and Prevention has more about flu antiviral drugs.

SOURCE: Clinical Infectious Diseases, news release, July 17, 2014

--


'/>"/>
Copyright©2014 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. RNs delayed retirement boosts US nursing supplies, study finds
2. National Study Finds Home Breakdowns Are Key Stress Triggers
3. Antibiotics Often Prescribed Needlessly for Terminally Ill, Study Finds
4. Study Suggests Tough Smoking Laws Might Lower Suicide Risk
5. Study: Smoking may contribute to suicide risk
6. Study: Robot-assisted surgery for prostate cancer controls the disease for 10 years
7. ORNL, UTGSM study compares structures of Huntingtons disease protein
8. Worm study provides hope for deadly disease of the brain
9. Surgery Soon After Stroke Can Be Risky: Study
10. Stroke Rates Declining Among Seniors, Study Shows
11. Study Warns of Kidney Damage Risk with Popular Mesothelioma Drug, Reports Surviving Mesothelioma
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Finds Many Flu Patients Not Treated Appropriately
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... ... 12, 2017 , ... The American College of Medical Informatics (ACMI) will present ... the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... Collen, a pioneer in the field of medical informatics, this prestigious award is presented ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a ... of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners ... October 11, 2017. , The annual award competition recognizes editorial and design excellence across ...
(Date:10/12/2017)... , ... October 12, 2017 , ... On Saturday, October ... treadmill relay – Miles by Moonlight to raise money for the American Heart Association ... more. , Teams will work together to keep their treadmills moving for 5 ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017   Montrium ... Master File solutions, today—from the IQPC Trial Master ... , NL)—announced that EastHORN Clinical Services has ... clinical programs and TMF management. EastHORN, a leading ... eTMF platform to increase transparency to enable greater ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
Breaking Medicine Technology: